Diagnosis of bladder cancer using

Animals Cell Line, Tumor Cell Transformation, Neoplastic Disease Models, Animal Fluorine Radioisotopes Humans Isotope Labeling Mice Phenylalanine / analogs & derivatives Positron-Emission Tomography Radioactive Tracers Tissue Distribution Urinary Bladder Neoplasms / diagnostic imaging
Bladder cancer F-18-labeled amino acid Mouse model PET imaging

Journal

Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398

Informations de publication

Date de publication:
May 2020
Historique:
received: 09 12 2019
accepted: 21 02 2020
pubmed: 8 3 2020
medline: 9 1 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

Although 2- We used the human bladder cancer cell line HT1376 to prepare a bladder cancer xenograft model in mice bearing both orthotopic and subcutaneous tumors. Biodistribution and PET imaging studies were performed at 1 and 3 h after injection of L-2- At 1 h after injection, greater accumulations of both L-2- Our study showed that L-2-

Identifiants

DOI: 10.1007/s12149-020-01452-z PMID: 32144655
pubmed: 32144655
doi: 10.1007/s12149-020-01452-z
pii: 10.1007/s12149-020-01452-z
doi:

Substances chimiques

Fluorine Radioisotopes 0
Radioactive Tracers 0
alpha-methylphenylalanine 4415-69-4
Phenylalanine 47E5O17Y3R
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

329-336

Auteurs

Isa Mahendra (I)

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan.
Center for Applied Nuclear Science and Technology, National Nuclear Energy Agency of Indonesia, Tamansari 71, Bandung, West Java, 40132, Indonesia.

Hirofumi Hanaoka (H)

Department of Bioimaging and Information Analysis, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan. hanaokah@gunma-u.ac.jp.

Aiko Yamaguchi (A)

Department of Bioimaging and Information Analysis, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan.
Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77054, USA.

Tumenjargal Amartuvshin (T)

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan.

Yoshito Tsushima (Y)

Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan.
Research Program for Diagnostic and Molecular Imaging, Division of Integrated Oncology Research, Gunma University Initiative for Advanced Research (GIAR), Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, 371-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Diagnosis of bladder cancer using
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Diagnosis of bladder cancer using
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Carcinogenèse › Transformation cellulaire néoplasique › Diagnosis of bladder cancer using
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Diagnosis of bladder cancer using
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du fluor › Diagnosis of bladder cancer using
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Diagnosis of bladder cancer using
questionsmedicales.fr › Techniques d'investigation › Marquage isotopique › Diagnosis of bladder cancer using
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Diagnosis of bladder cancer using
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés essentiels › Phénylalanine › Diagnosis of bladder cancer using
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Diagnosis of bladder cancer using
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Indicateurs et réactifs › Traceurs radioactifs › Diagnosis of bladder cancer using
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Pharmacocinétique › Distribution tissulaire › Diagnosis of bladder cancer using
questionsmedicales.fr › Maladies urogénitales › Maladies urologiques › Tumeurs urologiques › Tumeurs de la vessie urinaire › Diagnosis of bladder cancer using